Skip to main content
logo
Pharmaids Pharmaceuticals Limited (BOM:524572)
India flag India · Delayed Price · Currency is INR
33.39
-0.05 (-0.15%)
At close: Aug 17, 2026

Pharmaids Pharmaceuticals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
253.48278.82194.47151.12-39.39
Revenue Growth
18.56%43.37%28.69%---53.93%
Gross Profit
100.84107.362.126.02-9.043.68
Operating Income
-107.71-155.65-151.75-140.2-99.081.28
Net Income
-45.6-117.17-107.77-79.68-75.561.45
Earnings Per Share
-1.29-3.31-3.06-3.51-5.860.14
EPS Growth
-----55.56%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1.341.3421.4548.04160.594.07
Total Debt
233.82233.82389.7585.33--
Net Cash (Debt)
-232.49-232.49-368.3-37.29160.594.07
Net Cash Growth
----3841.48%103.44%
Net Cash Per Share
-6.57-6.57-10.44-1.6412.450.40

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--40.57-139.91-106.2-40.19-2.59
Capital Expenditures
--44.72-124.81-228.63-16.73-
Free Cash Flow
--85.29-264.72-334.82-56.92-2.59
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
39.78%38.48%31.93%17.21%-9.34%
Operating Margin
-42.49%-55.82%-78.03%-92.77%-3.25%
Pretax Margin
-26.50%-58.47%-88.85%-103.37%-3.56%
Profit Margin
-17.99%-42.02%-55.41%-52.73%-3.69%
FCF Margin
--30.59%-136.12%-221.56%--6.58%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
-----88.87
PS Ratio
4.653.5012.4512.14-3.28